Equities

Enfusion Inc

ENFN:NYQ

Enfusion Inc

Actions
TechnologyTechnology
  • Price (USD)9.57
  • Today's Change0.05 / 0.53%
  • Shares traded255.94k
  • 1 Year change+13.93%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Enfusion, Inc. provides software-as-a-service (SaaS) platform for investment managers. The Company, through its software, analytics, and middle/back-office managed services, creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration. The Company's cloud-native, end-to-end solution gives its clients the ability to access and analyze investment information in real time, perform complex calculations and interact with markets electronically adding up to better, more informed investment decisions and actions. Its solution is highly configurable to different work streams, client segments and asset classes. The Company's solution includes portfolio management system, order and execution management system, accounting/general ledger system, Enfusion Analytics System and technology-powered, managed services. Its solution is utilized by a variety of users, including portfolio managers, traders, compliance officers, operational support staff and executive management.

  • Revenue in USD (TTM)174.54m
  • Net income in USD6.33m
  • Incorporated2007
  • Employees1.10k
  • Location
    Enfusion Inc125 South Clark Street, Suite 750CHICAGO 60603United StatesUSA
  • Phone+1 (312) 253-9800
  • Fax+1 (302) 655-5049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nerdwallet Inc591.70m-12.40m1.07bn730.00--2.8329.821.81-0.1621-0.16217.604.871.32--5.98810,547.90-2.76---3.24--90.81---2.10------0.00--11.23---15.69------
Adeia Inc388.79m67.37m1.08bn130.0016.192.996.622.770.61350.61353.533.320.3357--7.872,990,677.005.822.626.582.85----17.337.83--2.330.621656.58-11.42-0.8691-52.43---3.13-24.21
A10 Networks Inc254.68m45.74m1.13bn525.0024.985.2620.274.430.60660.60663.382.880.67652.174.14485,112.4012.1511.0817.0316.5880.6978.9117.9614.902.23----20.70-10.221.62-14.79--31.25--
Hello Group Inc (ADR)1.66bn270.38m1.15bn1.38k4.600.71563.950.69111.351.358.258.650.7488--61.511,199,534.0012.625.8616.256.9841.4744.9016.857.99----0.153583.05-5.52-2.1931.89-7.0118.87--
Fastly Inc521.94m-131.83m1.16bn1.21k--1.17--2.22-1.00-1.003.987.270.3099--5.41432,430.80-7.83-10.78-8.44-11.6953.5153.04-25.26-38.90----0.2643--16.9328.4730.24--10.42--
PubMatic Inc267.01m8.88m1.17bn948.00270.713.9721.844.390.08660.08664.685.890.3993--0.7742281,660.301.335.772.7111.5762.8468.843.3312.58----0.000.004.1521.88-69.06--23.98--
Amplitude Inc276.28m-90.36m1.21bn675.00--4.09--4.38-0.775-0.7752.362.460.652--10.58409,309.60-21.33---29.82--73.97---32.71------0.00--16.05--3.23------
Opera Ltd (ADR)412.53m152.66m1.22bn592.008.121.357.362.951.701.704.5610.200.4321--7.27696,836.1015.993.9517.344.2675.6787.0837.0115.24----0.011852.7319.9119.76919.6334.98-4.09--
Enfusion Inc174.54m6.33m1.23bn1.10k133.7522.7463.717.020.07160.07161.350.42081.50--6.47158,380.207.95--13.93--66.97--5.30------0.00--16.09--173.55------
Phreesia Inc356.30m-136.89m1.26bn1.44k--5.00--3.53-2.51-2.516.534.460.9625--6.13247,774.00-36.98-30.60-49.67-38.0665.1963.36-38.42-42.60----0.0436--26.8428.9622.29--20.61--
Angi Inc1.36bn-30.68m1.28bn3.80k--1.2317.830.9385-0.0607-0.08102.692.060.722--18.74357,565.30-1.60-1.51-1.87-1.7595.4088.14-2.21-2.02---15.140.322---22.993.7165.78--0.34--
Magnite Inc619.71m-159.18m1.30bn911.00--1.8315.872.09-1.18-1.184.545.060.2295--0.5757680,252.50-5.89-4.45-11.08-8.1533.8648.42-25.69-18.03---4.300.4333--7.3937.81-22.15--13.39--
FinVolution Group (ADR)1.73bn323.32m1.30bn3.65k4.350.739--0.75121.151.156.186.780.588--5.67475,068.1011.1712.7912.0615.0783.1781.7319.0024.64----0.000412.0712.6923.593.29-1.0643.41--
Taboola.com Ltd1.44bn-82.04m1.31bn1.90k--1.2490.320.908-0.2379-0.23794.153.580.8894--5.11757,728.90-5.07---6.71--29.5628.95-5.70-2.13---4.860.1208--2.759.63-585.09---0.0149--
Meridianlink Inc303.62m-42.54m1.32bn676.00--2.6685.974.34-0.536-0.5363.786.480.2954--8.43449,137.60-4.14---4.37--64.27---14.01----0.50460.4546--5.41---3,387.40------
Data as of May 03 2024. Currency figures normalised to Enfusion Inc's reporting currency: US Dollar USD

Institutional shareholders

50.56%Per cent of shares held by top holders
HolderShares% Held
ICONIQ Capital LLCas of 31 Dec 202314.04m15.62%
Brown Capital Management LLCas of 31 Dec 202311.82m13.15%
HHLR Advisors Ltd.as of 31 Dec 20234.98m5.54%
The Vanguard Group, Inc.as of 31 Dec 20233.51m3.91%
Ararat Capital Management LPas of 31 Dec 20232.58m2.88%
BlackRock Fund Advisorsas of 31 Dec 20232.25m2.51%
12 West Capital Management LPas of 31 Dec 20231.90m2.12%
Janus Henderson Investors US LLCas of 31 Dec 20231.63m1.82%
New York State Common Retirement Fundas of 31 Dec 20231.62m1.80%
Nellore Capital Management LLCas of 31 Dec 20231.11m1.23%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.